(Q44635875)

4 December 2017

title

Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity (English)

1 reference

4 December 2017

1 reference

Ilan Ifergan

1

1 reference

4 December 2017

Issac Meller

series ordinal

2

1 reference

4 December 2017

Josefin Issakov

series ordinal

3

1 reference

4 December 2017

Yehuda G Assaraf

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

98

1 reference

4 December 2017

issue

9

1 reference

4 December 2017

page(s)

1958-1966

1 reference

Etiology of osteosarcoma.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Serum methotrexate (MTX) concentrations and prognosis in patients with osteosarcoma of the extremities treated with a multidrug neoadjuvant regimen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Prognostic significance of chemotherapy dosage characteristics in children with osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Karnofsky memorial lecture. Ode to methotrexate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Mammalian ABC transporters in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

MRP3, an organic anion transporter able to transport anti-cancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Alterations in the expression of transcription factors and the reduced folate carrier as a novel mechanism of antifolate resistance in human leukemia cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Pattern of mutations that results in loss of reduced folate carrier function under antifolate selective pressure augmented by chemical mutagenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Intrinsic and acquired resistance to methotrexate in acute leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Capillary electrophoretic drug monitoring of methotrexate and leucovorin and their metabolites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11741

7 January 2021

Identifiers

DOI

10.1002/CNCR.11741

1 reference

4 December 2017

1 reference